Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer [Phase 2]
Phase 2 trial update for S-588410 after adjuvant chemotherapy in completely resected non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer [NA]
Trial update on safety of LEAD radiotherapy plus chemoradiation in bulky stage III non-small cell lung cancer; the study was terminated with…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy [Phase 2]
This document summarizes a completed Phase II trial evaluating cisplatin-docetaxel induction followed by concurrent 3-D conformal radiothera…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib [Phase 2]
Phase 2 trial evaluating erlotinib in combination with BKM120 in advanced non-small cell lung cancer patients previously sensitive to erloti…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of apatinib with radiotherapy for brain metastases in patients with non-small cell lu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluated hypofractionated proton beam radiation therapy in combination with paclitaxel and carboplatin for stage II-III non…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC [Phase 2]
This Phase 2 trial investigates hippocampus-sparing whole-brain radiotherapy with a simultaneous integrated boost for brain metastases from …
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer. [Phase 2]
Phase 2 trial evaluating dabrafenib alone or in combination with trametinib for BRAF V600E metastatic non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) [Phase 2]
Phase 2 trial comparing stereotactic body radiotherapy (SBRT) with stereotactic body proton therapy (SBPT) for non-small cell lung cancer wa…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update across multiple cancer types including ovarian, non-small cell lung, prostate, colorectal, gastric/esophageal,…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) [Phase 1, Phase 2]
Clinical trial update for pembrolizumab combined with chemotherapy or immunotherapy in non-small cell lung cancer (KEYNOTE-021) from phase 1…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer [Phase 1]
The document reports a Phase 1 trial evaluating bronchial artery infusion of gemcitabine for recurrent or progressive non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC [Phase 1]
Phase 1 trial evaluating oxaliplatin and docetaxel with radiation therapy in unresectable stage II/III or recurrent non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy [Phase 2]
This Phase 2 trial in advanced non-small cell lung cancer investigates genotype-guided first-line chemotherapy based on ERCC1 and RRM1 mRNA …
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer [Phase 1]
Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of GDC-0032 (taselisib) in combination with docetaxel or…
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC [Phase 4]
Phase 4 trial evaluating intercalating and maintenance gefitinib with chemotherapy for advanced EGFR-mutant non-small cell lung cancer has b…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating trastuzumab emtansine in HER2 IHC-positive locally advanced or metastatic non-small cell lung cancer has completed …
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma [Phase 1]
Phase 1 trial update of NPI-0052 (marizomib) and vorinostat in patients with non-small cell lung cancer, pancreatic cancer, melanoma, lympho…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 study evaluating linifanib (ABT-869) in combination with carboplatin and paclitaxel in Japanese patients with non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
This clinical trial update reports completion of a Phase 1b study of volociximab in combination with carboplatin and paclitaxel as first-lin…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating icotinib in plasma ctDNA EGFR mutation-positive non-small cell lung cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors [Phase 1]
A Phase I study evaluating pazopanib in combination with either erlotinib or pemetrexed in patients with advanced solid tumors, including no…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors [Phase 1]
Phase 1 trial of IR-guided ablation combined with stereotactic ablative radiation for large recurrent non-small cell lung cancer has been te…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase [Phase 1]
Phase II trial of lapatinib (TYKERB) plus pemetrexed (ALIMTA) in advanced non-small cell lung cancer has completed. The study included an in…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors [Phase 1]
A Phase I, open-label study evaluating pazopanib in combination with gemcitabine, with or without cisplatin, in patients with advanced solid…